Home
Investors
Sientra.com
Overview
News
Events
Financial Info
Quarterly Reports
SEC Filings
Stock Info
Quote & Chart
Analyst Coverage
Governance
Documents & Charters
Management
Board of Directors
Committee Composition
Resources
FAQs
E-mail Alerts
RSS Feeds
contact IR
News
Elieen, Actual Sientra Patient
Normal
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Sientra to Present at the H.C. Wainwright Bioconnect Virtual Conference
December 27, 2021
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
December 17, 2021
Sientra Selects Leading Distributors for Two Key International Markets In Preparation for Further Expansion and Growth Acceleration
December 2, 2021
Sientra Reports Record Third Quarter 2021 Revenue for Continuing Operations
November 10, 2021
Sientra to Participate in Upcoming Investor Conferences
November 1, 2021
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
October 28, 2021
Sientra to Report Third Quarter 2021 Financial Results on Wednesday, November 10, 2021
October 27, 2021
Sientra® And Mission Plasticos Launch Reshaping Lives: Full Circle™ A Philanthropic Initiative For Women Living In Poverty In America
October 19, 2021
New Study Confirms Sientra’s AlloX2’s Unique Value in Managing Seroma and Infection Post Reconstruction Procedures
August 25, 2021
Sientra Reports Record Breast Products Revenue for Second Quarter 2021, Raises Revenue Guidance for Full Year 2021
August 10, 2021
Sientra to Report Second Quarter 2021 Financial Results on Tuesday, August 10, 2021
July 27, 2021
Sientra Appoints Two Medical Aesthetics Leaders to its Board of Directors
July 19, 2021
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
July 16, 2021
Sientra Announces Appointment of Chief Financial Officer
July 12, 2021
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
June 29, 2021
Sientra Announces Closing of Previously Announced Sale of miraDry Business to 1315 Capital
June 11, 2021
Sientra Announces Addition of Vice President of Research & Development
June 1, 2021
Sientra to Participate in Upcoming Virtual Investor Conferences
May 18, 2021
Sientra Reports Record First Quarter 2021 Financial Results
May 11, 2021
Sientra Announces Sale of miraDry Business to 1315 Capital
May 11, 2021
Sientra Receives Innovative Technology Contract from Vizient for AlloX2® Tissue Expander
May 5, 2021
Sientra and Butterfly Network Announce Strategic Partnership to Improve Diagnostic Surveillance of Breast Implant Patients
April 30, 2021
Sientra to Report First Quarter 2021 Financial Results on May 11, 2021
April 27, 2021
Sientra Reports Fourth Quarter and Full Year 2020 Financial Results
March 11, 2021
Sientra Announces Departure of CFO and Appointment of Interim CFO
March 11, 2021
Sientra to Report Fourth Quarter and Full Year 2020 Financial Results on March 11, 2021
February 25, 2021
Sientra to Present at the SVB Leerink 10th Annual Global Healthcare Conference
February 11, 2021
Sientra Announces Pricing of Public Offering of Common Stock
February 8, 2021
Sientra Commences Public Offering of Common Stock
February 8, 2021
Sientra Reports Preliminary Fourth Quarter and Full Year 2020 Results
February 4, 2021
Nasdaq: SIEN
Stock Quote:
NASD
$
1.58
-
0.09
Volume
200,163
Previous Close
1.67
Intraday High
1.67
Intraday Low
1.39
Pricing delayed 20 minutes
Price
Change
% Change
-
5.61%
52 Week High
23.05
52 Week Low
1.28
Today's Open
1.60
Mar 31, 2023 03:57 PM
Email Alerts
Email:
*
Subscription Preferences
*
Press Release
SEC Filing
Event
EOD Stock Quote
Enter the code shown above.
Investor Contact
Sientra Investor Relations
ir@sientra.com
Privacy Statement
|
Terms of use
|
Safety
|
Compliance
|
Resources
|
Patents
|
Contact Us
|
Careers
© 2021 Sientra, Inc. All rights reserved.